What is involved in a second trimester ultrasound?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Second Trimester Ultrasound: A Pictorial Guide

Optimal Timing and Approach

The second trimester anatomic ultrasound should be performed between 20-22 weeks gestation, as this timing provides the highest completion rates (88-90%) and minimizes the need for repeat scanning compared to earlier gestational ages. 1

  • Performing the scan at 18 weeks results in significantly lower completion rates (76%) due to higher incidence of non-cephalic presentation (46% vs 36%) and difficulty visualizing thorax, heart, spine, and skeletal structures. 1
  • The examination is performed transabdominally using high-resolution real-time ultrasound with systematic evaluation of fetal anatomy. 2
  • Transvaginal ultrasound can supplement transabdominal scanning when fetal parts are close to the cervix or in obese women between 12-16 weeks to improve anatomic visualization. 2

Standard Anatomic Survey Components

Head and Brain

  • Measure biparietal diameter (BPD) and head circumference in the standard axial plane at the level of the thalami and cavum septi pellucidi. 3
  • Visualize the lateral ventricles, choroid plexus, midline falx, cavum septi pellucidi, and posterior fossa including cerebellum and cisterna magna. 4
  • Transverse cerebellar diameter (TCD) is particularly useful as it is relatively spared in growth restriction. 3

Face and Neck

  • Document the profile view to assess for facial clefts, micrognathia, and nasal bone presence. 2
  • Evaluate for nuchal fold thickness, which should be ≤6 mm; thickness >6 mm has 34% sensitivity for Down syndrome with 1.5% false positive rate. 3
  • Screen for cystic hygroma and other neck masses. 2

Spine

  • Examine the spine in both sagittal and axial planes from cervical to sacral regions to exclude neural tube defects. 4
  • Verify intact skin covering and normal alignment of vertebral bodies. 4

Thorax

  • Perform four-chamber heart view to assess cardiac size, position, axis, and chamber symmetry. 4
  • Evaluate for diaphragmatic hernias and congenital pulmonary airway malformations. 2
  • Document normal lung echogenicity and exclude pleural effusions. 4

Abdomen

  • Visualize stomach bubble in left upper quadrant and assess abdominal wall integrity. 4
  • Screen for gastroschisis and omphalocele by confirming intact abdominal wall and normal cord insertion. 2
  • Measure abdominal circumference at the level of stomach and umbilical vein. 3
  • Evaluate kidneys bilaterally and bladder; measure renal pelvis diameter (pyelectasis if >4mm). 2

Extremities

  • Measure femur length and humerus length; short long bones (below expected for gestational age) have 30% sensitivity for aneuploidy with <5% false positive rate. 3
  • Document presence of all four limbs with normal bone mineralization. 2
  • Evaluate hands and feet when visible. 4

Placenta and Amniotic Fluid

  • Document placental location; note that low-lying placenta is more commonly identified at 18 weeks and often resolves by term. 1
  • Assess amniotic fluid volume qualitatively or quantitatively. 4

Soft Markers and Their Significance

When soft markers are identified, their clinical significance depends heavily on whether the patient has already undergone genetic screening (first trimester screening, cell-free DNA, or invasive testing). 2

Common Soft Markers

  • Echogenic intracardiac focus, choroid plexus cysts, renal pyelectasis, short humerus/femur, nuchal thickening (≥6mm), echogenic bowel, and short/absent nasal bone are associated with aneuploidy risk. 2
  • For isolated echogenic intracardiac focus or choroid plexus cyst alone, detailed anatomic scan is optional if the finding is truly isolated. 2
  • For other soft markers (renal pyelectasis, short bones, nuchal thickening, echogenic bowel, absent nasal bone), a detailed scan is usually indicated to ensure the finding is isolated. 2

Important Context

  • If the patient has had normal karyotype analysis (CVS/amniocentesis) or cell-free DNA testing, soft markers lose their relevance for aneuploidy risk and should not alter management. 2
  • The introduction of first trimester screening and NIPT has reduced the clinical utility of soft markers, with greater impact on false positive rates than detection rates. 2

When to Perform Detailed/Targeted Ultrasound

A detailed fetal anatomic examination is indicated when: 2

  • Major anomalies are suspected or identified on routine screening
  • The patient has high-risk factors (maternal medical conditions, family history, abnormal genetic screening)
  • Soft markers are identified and require confirmation of isolated finding
  • The routine anatomy scan is incomplete due to technical factors

Complementary Imaging

Fetal Echocardiography

  • Indicated based on parental risk factors (maternal diabetes, genetic syndromes, teratogen exposure) or abnormal cardiac screening on anatomy scan. 2

Fetal MRI

  • Generally indicated when ultrasound findings are incomplete or require additional detail, ideally performed at or after 22 weeks gestation. 2
  • Particularly helpful for central nervous system anomalies, neck masses requiring airway planning, and complex thoracic/abdominal pathology. 2
  • MRI without contrast only; contrast is not indicated for fetal evaluation. 2

Safety Considerations

  • Long-term follow-up studies show no detrimental effects on cognitive or physical development in children exposed to ultrasound in utero. 2, 5
  • Highest energy output occurs with Doppler ultrasound; familiarity with safety protocols is recommended. 2
  • Doppler imaging should be used judiciously to assess vessels and organs when clinically indicated. 2

Detection Rates

  • Second trimester ultrasound detects 55% of major malformations before 24 weeks in unselected populations. 2
  • Detection improves to 75-90% for open neural tube defects and 95% for anencephaly when combined with maternal serum alpha-fetoprotein screening. 2
  • Routine second trimester ultrasound increases detection of major fetal abnormalities before 24 weeks (RR 3.45) and termination for major anomaly (RR 2.36). 5

Common Pitfalls to Avoid

  • Do not perform anatomy scan at 18 weeks routinely; wait until 20-22 weeks to maximize completion rates and minimize repeat scans. 1
  • Ensure accurate gestational age dating before interpreting measurements; ultrasound dating in first trimester is most accurate (±5-7 days). 6, 7
  • Do not over-interpret soft markers in patients who have had normal genetic screening or invasive testing. 2
  • Recognize limitations including maternal obesity, fetal position, and oligohydramnios that may necessitate repeat scanning. 2

References

Research

Feasibility of the second-trimester fetal ultrasound examination in an unselected population at 18, 20 or 22 weeks of pregnancy: a randomized trial.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology, 1999

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

First and second trimester sonography: an American perspective.

International journal of fertility and menopausal studies, 1996

Research

A pictorial guide for the second trimester ultrasound.

Australasian journal of ultrasound in medicine, 2013

Research

Routine ultrasound for fetal assessment before 24 weeks' gestation.

The Cochrane database of systematic reviews, 2021

Guideline

Management of Gestational Age Discrepancies

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Determining the Due Date in Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.